1632 related articles for article (PubMed ID: 34043894)
1. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
Frenck RW; Klein NP; Kitchin N; Gurtman A; Absalon J; Lockhart S; Perez JL; Walter EB; Senders S; Bailey R; Swanson KA; Ma H; Xu X; Koury K; Kalina WV; Cooper D; Jennings T; Brandon DM; Thomas SJ; Türeci Ö; Tresnan DB; Mather S; Dormitzer PR; Şahin U; Jansen KU; Gruber WC;
N Engl J Med; 2021 Jul; 385(3):239-250. PubMed ID: 34043894
[TBL] [Abstract][Full Text] [Related]
2. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Walsh EE; Frenck RW; Falsey AR; Kitchin N; Absalon J; Gurtman A; Lockhart S; Neuzil K; Mulligan MJ; Bailey R; Swanson KA; Li P; Koury K; Kalina W; Cooper D; Fontes-Garfias C; Shi PY; Türeci Ö; Tompkins KR; Lyke KE; Raabe V; Dormitzer PR; Jansen KU; Şahin U; Gruber WC
N Engl J Med; 2020 Dec; 383(25):2439-2450. PubMed ID: 33053279
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Polack FP; Thomas SJ; Kitchin N; Absalon J; Gurtman A; Lockhart S; Perez JL; Pérez Marc G; Moreira ED; Zerbini C; Bailey R; Swanson KA; Roychoudhury S; Koury K; Li P; Kalina WV; Cooper D; Frenck RW; Hammitt LL; Türeci Ö; Nell H; Schaefer A; Ünal S; Tresnan DB; Mather S; Dormitzer PR; Şahin U; Jansen KU; Gruber WC;
N Engl J Med; 2020 Dec; 383(27):2603-2615. PubMed ID: 33301246
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
Thomas SJ; Moreira ED; Kitchin N; Absalon J; Gurtman A; Lockhart S; Perez JL; Pérez Marc G; Polack FP; Zerbini C; Bailey R; Swanson KA; Xu X; Roychoudhury S; Koury K; Bouguermouh S; Kalina WV; Cooper D; Frenck RW; Hammitt LL; Türeci Ö; Nell H; Schaefer A; Ünal S; Yang Q; Liberator P; Tresnan DB; Mather S; Dormitzer PR; Şahin U; Gruber WC; Jansen KU;
N Engl J Med; 2021 Nov; 385(19):1761-1773. PubMed ID: 34525277
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
Muñoz FM; Sher LD; Sabharwal C; Gurtman A; Xu X; Kitchin N; Lockhart S; Riesenberg R; Sexter JM; Czajka H; Paulsen GC; Maldonado Y; Walter EB; Talaat KR; Englund JA; Sarwar UN; Hansen C; Iwamoto M; Webber C; Cunliffe L; Ukkonen B; Martínez SN; Pahud BA; Munjal I; Domachowske JB; Swanson KA; Ma H; Koury K; Mather S; Lu C; Zou J; Xie X; Shi PY; Cooper D; Türeci Ö; Şahin U; Jansen KU; Gruber WC;
N Engl J Med; 2023 Feb; 388(7):621-634. PubMed ID: 36791162
[TBL] [Abstract][Full Text] [Related]
6. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
Munro APS; Feng S; Janani L; Cornelius V; Aley PK; Babbage G; Baxter D; Bula M; Cathie K; Chatterjee K; Dodd K; Enever Y; Qureshi E; Goodman AL; Green CA; Harndahl L; Haughney J; Hicks A; van der Klaauw AA; Kanji N; Libri V; Llewelyn MJ; McGregor AC; Maallah M; Minassian AM; Moore P; Mughal M; Mujadidi YF; Holliday K; Osanlou O; Osanlou R; Owens DR; Pacurar M; Palfreeman A; Pan D; Rampling T; Regan K; Saich S; Bawa T; Saralaya D; Sharma S; Sheridan R; Thomson EC; Todd S; Twelves C; Read RC; Charlton S; Hallis B; Ramsay M; Andrews N; Lambe T; Nguyen-Van-Tam JS; Snape MD; Liu X; Faust SN;
Lancet Infect Dis; 2022 Aug; 22(8):1131-1141. PubMed ID: 35550261
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
Ali K; Berman G; Zhou H; Deng W; Faughnan V; Coronado-Voges M; Ding B; Dooley J; Girard B; Hillebrand W; Pajon R; Miller JM; Leav B; McPhee R
N Engl J Med; 2021 Dec; 385(24):2241-2251. PubMed ID: 34379915
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Liu X; Shaw RH; Stuart ASV; Greenland M; Aley PK; Andrews NJ; Cameron JC; Charlton S; Clutterbuck EA; Collins AM; Dinesh T; England A; Faust SN; Ferreira DM; Finn A; Green CA; Hallis B; Heath PT; Hill H; Lambe T; Lazarus R; Libri V; Long F; Mujadidi YF; Plested EL; Provstgaard-Morys S; Ramasamy MN; Ramsay M; Read RC; Robinson H; Singh N; Turner DPJ; Turner PJ; Walker LL; White R; Nguyen-Van-Tam JS; Snape MD;
Lancet; 2021 Sep; 398(10303):856-869. PubMed ID: 34370971
[TBL] [Abstract][Full Text] [Related]
9. Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Halperin SA; Ye L; MacKinnon-Cameron D; Smith B; Cahn PE; Ruiz-Palacios GM; Ikram A; Lanas F; Lourdes Guerrero M; Muñoz Navarro SR; Sued O; Lioznov DA; Dzutseva V; Parveen G; Zhu F; Leppan L; Langley JM; Barreto L; Gou J; Zhu T;
Lancet; 2022 Jan; 399(10321):237-248. PubMed ID: 34953526
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
Xia S; Zhang Y; Wang Y; Wang H; Yang Y; Gao GF; Tan W; Wu G; Xu M; Lou Z; Huang W; Xu W; Huang B; Wang H; Wang W; Zhang W; Li N; Xie Z; Ding L; You W; Zhao Y; Yang X; Liu Y; Wang Q; Huang L; Yang Y; Xu G; Luo B; Wang W; Liu P; Guo W; Yang X
Lancet Infect Dis; 2021 Jan; 21(1):39-51. PubMed ID: 33069281
[TBL] [Abstract][Full Text] [Related]
11. Homologous and Heterologous Covid-19 Booster Vaccinations.
Atmar RL; Lyke KE; Deming ME; Jackson LA; Branche AR; El Sahly HM; Rostad CA; Martin JM; Johnston C; Rupp RE; Mulligan MJ; Brady RC; Frenck RW; Bäcker M; Kottkamp AC; Babu TM; Rajakumar K; Edupuganti S; Dobrzynski D; Coler RN; Posavad CM; Archer JI; Crandon S; Nayak SU; Szydlo D; Zemanek JA; Dominguez Islas CP; Brown ER; Suthar MS; McElrath MJ; McDermott AB; O'Connell SE; Montefiori DC; Eaton A; Neuzil KM; Stephens DS; Roberts PC; Beigel JH;
N Engl J Med; 2022 Mar; 386(11):1046-1057. PubMed ID: 35081293
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.
Creech CB; Anderson E; Berthaud V; Yildirim I; Atz AM; Melendez Baez I; Finkelstein D; Pickrell P; Kirstein J; Yut C; Blair R; Clifford RA; Dunn M; Campbell JD; Montefiori DC; Tomassini JE; Zhao X; Deng W; Zhou H; Ramirez Schrempp D; Hautzinger K; Girard B; Slobod K; McPhee R; Pajon R; Das R; Miller JM; Schnyder Ghamloush S;
N Engl J Med; 2022 May; 386(21):2011-2023. PubMed ID: 35544369
[TBL] [Abstract][Full Text] [Related]
13. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
[TBL] [Abstract][Full Text] [Related]
14. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.
Rabinowich L; Grupper A; Baruch R; Ben-Yehoyada M; Halperin T; Turner D; Katchman E; Levi S; Houri I; Lubezky N; Shibolet O; Katchman H
J Hepatol; 2021 Aug; 75(2):435-438. PubMed ID: 33892006
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
Walter EB; Talaat KR; Sabharwal C; Gurtman A; Lockhart S; Paulsen GC; Barnett ED; Muñoz FM; Maldonado Y; Pahud BA; Domachowske JB; Simões EAF; Sarwar UN; Kitchin N; Cunliffe L; Rojo P; Kuchar E; Rämet M; Munjal I; Perez JL; Frenck RW; Lagkadinou E; Swanson KA; Ma H; Xu X; Koury K; Mather S; Belanger TJ; Cooper D; Türeci Ö; Dormitzer PR; Şahin U; Jansen KU; Gruber WC;
N Engl J Med; 2022 Jan; 386(1):35-46. PubMed ID: 34752019
[TBL] [Abstract][Full Text] [Related]
16. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
Sadoff J; Le Gars M; Shukarev G; Heerwegh D; Truyers C; de Groot AM; Stoop J; Tete S; Van Damme W; Leroux-Roels I; Berghmans PJ; Kimmel M; Van Damme P; de Hoon J; Smith W; Stephenson KE; De Rosa SC; Cohen KW; McElrath MJ; Cormier E; Scheper G; Barouch DH; Hendriks J; Struyf F; Douoguih M; Van Hoof J; Schuitemaker H
N Engl J Med; 2021 May; 384(19):1824-1835. PubMed ID: 33440088
[TBL] [Abstract][Full Text] [Related]
17. Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
Formica N; Mallory R; Albert G; Robinson M; Plested JS; Cho I; Robertson A; Dubovsky F; Glenn GM;
PLoS Med; 2021 Oct; 18(10):e1003769. PubMed ID: 34597298
[TBL] [Abstract][Full Text] [Related]
18. A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.
Haranaka M; Baber J; Ogama Y; Yamaji M; Aizawa M; Kogawara O; Scully I; Lagkadinou E; Türeci Ӧ; Şahin U; Dormitzer PR; Gruber WC; Lockhart S
Nat Commun; 2021 Dec; 12(1):7105. PubMed ID: 34907170
[TBL] [Abstract][Full Text] [Related]
19. Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial.
Áñez G; Dunkle LM; Gay CL; Kotloff KL; Adelglass JM; Essink B; Campbell JD; Cloney-Clark S; Zhu M; Plested JS; Roychoudhury P; Greninger AL; Patel N; McGarry A; Woo W; Cho I; Glenn GM; Dubovsky F;
JAMA Netw Open; 2023 Apr; 6(4):e239135. PubMed ID: 37099299
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.
Anderson EJ; Creech CB; Berthaud V; Piramzadian A; Johnson KA; Zervos M; Garner F; Griffin C; Palanpurwala K; Turner M; Gerber J; Bennett RL; Ali K; Ampajwala M; Berman G; Nayak J; Chronis C; Rizzardi B; Muller WJ; Smith CA; Fuchs G; Hsia D; Tomassini JE; DeLucia D; Reuter C; Kuter B; Zhao X; Deng W; Zhou H; Ramirez Schrempp D; Hautzinger K; Girard B; Slobod K; McPhee R; Pajon R; Aunins A; Das R; Miller JM; Schnyder Ghamloush S;
N Engl J Med; 2022 Nov; 387(18):1673-1687. PubMed ID: 36260859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
